Mimedx (MDXG) Cash from Operations (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.47% |
| Dec 31, 2025 | -14.91% |
| Sep 30, 2025 | 103.41% |
| Jun 30, 2025 | 172.11% |
| Mar 31, 2025 | -73.12% |
| Dec 31, 2024 | 5.45% |
| Sep 30, 2024 | -17.81% |
| Jun 30, 2024 | 280.46% |
| Mar 31, 2024 | -41.72% |
| Dec 31, 2023 | -19.81% |
| Sep 30, 2023 | 64.51% |
| Jun 30, 2023 | 292.07% |
| Mar 31, 2023 | -194.21% |
| Dec 31, 2022 | 348.07% |
| Sep 30, 2022 | 131.91% |
| Jun 30, 2022 | 70.61% |
| Mar 31, 2022 | 8.10% |
| Dec 31, 2021 | -275.73% |
| Sep 30, 2021 | 295.87% |
| Jun 30, 2021 | 123.94% |
| Mar 31, 2021 | 34.95% |
| Dec 31, 2020 | -122.33% |
| Sep 30, 2020 | -49.11% |
| Jun 30, 2020 | 74.78% |
| Mar 31, 2020 | 46.89% |
| Dec 31, 2019 | -631.71% |
| Sep 30, 2019 | -248.36% |
| Jun 30, 2019 | 113.96% |
| Mar 31, 2019 | -1,094.78% |
| Dec 31, 2018 | -54.84% |
| Sep 30, 2018 | -83.58% |
| Jun 30, 2018 | 103.31% |
| Mar 31, 2018 | -51.23% |
| Dec 31, 2017 | 16.23% |
| Sep 30, 2017 | 33.14% |
| Jun 30, 2017 | 26.72% |
| Mar 31, 2017 | -27.62% |
| Dec 31, 2016 | 416.73% |
| Sep 30, 2016 | -60.92% |
| Jun 30, 2016 | 845.14% |
| Mar 31, 2016 | -122.43% |
| Dec 31, 2015 | -40.39% |
| Sep 30, 2015 | 149.16% |
| Jun 30, 2015 | -30.33% |
| Mar 31, 2015 | -49.19% |
| Dec 31, 2014 | -7.40% |
| Sep 30, 2014 | 658.31% |
| Jun 30, 2014 | 173.20% |
| Mar 31, 2014 | -291.75% |
| Dec 31, 2013 | -51.38% |
| Sep 30, 2013 | 328.88% |
| Jun 30, 2013 | 64.00% |
| Mar 31, 2013 | -140.93% |
| Dec 31, 2012 | -1.00% |
| Sep 30, 2012 | -177.38% |
| Jun 30, 2012 | 75.86% |
| Mar 31, 2012 | 22.21% |
| Dec 31, 2011 | -51.96% |
| Sep 30, 2011 | 48.84% |
| Jun 30, 2011 | -18.99% |